Pre-eclampsia (Q81446389)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Pre-eclampsia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1

Baha Sibai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Gus Dekker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Michael Kupferminc

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

9461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

785-799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and management of gestational hypertension and preeclampsia

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Is pre-eclampsia more than one disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Prevention of preeclampsia: a big disappointment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Primary, secondary, and tertiary prevention of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

World Health Organization systematic review of screening tests for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The detection, investigation and management of hypertension in pregnancy: executive summary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Pre-eclampsia and the hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Chronic hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Thrombophilia and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Risk for subsequent coronary artery disease after preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Outcomes in young adulthood for very-low-birth-weight infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The developmental origins of well-being

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Random urine protein-creatinine ratio to predict proteinuria in new-onset mild hypertension in late pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Eclampsia in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Sperm exposure and development of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Abortion, changed paternity, and risk of preeclampsia in nulliparous women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Association of rheumatologic disease with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal morbid obesity and the risk of adverse pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal periodontal disease is associated with an increased risk for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Paternal and maternal components of the predisposition to preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Fetal and maternal contributions to risk of pre-eclampsia: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The Interval between Pregnancies and the Risk of Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Obesity and preeclampsia: the potential role of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Implantation: can immunological parameters of implantation failure be of interest for pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Transforming growth factor beta--a mediator of immune deviation in seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Color Doppler imaging of the uteroplacental circulation in the first trimester: value in predicting pregnancy failure or complication.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Natural killer cells and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Etiology and pathogenesis of preeclampsia: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Trophoblast deportation and the maternal inflammatory response in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Recent Insights into the pathogenesis of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Th1/Th2 balance in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Preeclampsia: an excessive maternal inflammatory response to pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Pre-eclampsia: more than pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Platelets and the beginnings of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The annexinopathies: a new category of diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Immunohistochemical study of annexin V expression in placentae of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Genetic conflicts in human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The genetics of pre-eclampsia: a feto-placental or maternal problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Trial of Calcium to Prevent Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Expectant management of severe preeclampsia remote from term

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

The confidential enquiry into maternal and child health (CEMACH).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Fortnightly review: management of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Temporising management of severe pre-eclampsia with and without the HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Delayed postpartum preeclampsia: an experience of 151 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

Late postpartum eclampsia: a preventable disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917987-2

7 January 2021

10.1016/S0140-6736(05)17987-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733721%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference